Home
Research
Our publications

Our publications

These selected publications highlight the major themes of research at Mercy Perinatal. Further information on individual researchers and Obstetrics and Gynaecology Research at the University of Melbourne can be found here.

Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies.

Kaitu’u-Lino T, Pattison S, Ye L, Tuohey L, Sluka P, MacDiarmid J, Brahmbhatt H, Johns T, Horne A, Brown J, Tong S. Endo...
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of combination gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.

Horne AW, Skubisz M, Doust A, Duncan WC, Wallace EM, Critchley HOD, Johns T, Norman JE, Bhattacharya S, Mollison J, Rass...
Combination gefitinb and methotrexate treatment for non-tubal ectopic pregnancies: a case series.

Horne AW, Skubisz MM, Tong S, Duncan WC, Neil P, Wallace EM, Johns TG. Human Reproduction 2014; 29(7):1375-9.
Molecular diagnostics and therapeutics for ectopic pregnancy.

Tong S, Skubisz MM, Horne AH. Molecular Human Reproduction. 2015; 21(2): 126-135.
Treatment of early-onset preeclampsia with continuous positive airway pressure.

Fung AM, Wilson DL, Lappas M, Howard M, Barnes M, O'Donoghue F, Tong S, Esdale H, Fleming G, Walker SP. PLoS One 2013; 8...
Obstructive sleep apnea and pregnancy: the effect on perinatal outcomes.

Fung AM, Wilson DL, Barnes M, Walker SP. Journal of Perinatology 2012; 32(6):399-406.
Can we predict sleep-disordered breathing in pregnancy? The clinical utility of symptoms.

Wilson DL, Walker SP, Fung AM, O'Donoghue F, Barnes M, Howard M. Journal of Sleep Research 2013; 22(6):670-8.
Identifying late onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks gestation.

Whitehead CL, McNamara H, Walker SP, Alexiadis M, Fuller P, Vickers DK, Hastie R, Tuohey L, Hannan NJ, Kaitu’u-Lino TJ, ...
Placental insufficiency in fetuses that slow in growth but are born appropriate for gestational age: A prospective longitudinal study.

Bardien N, Whitehead CL, Tong S, Ugoni A, McDonald D, Walker SP. PLoS One 2016; 11(1): e0142788.
Measuring hypoxia-induced RNA in maternal blood: a new way to identify critically hypoxic fetuses in utero?

Whitehead CL, Tong S. Expert Reviews in Molecular Diagnostics 2014; 14(5):509-11.

Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies.

Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of combination gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.

Combination gefitinb and methotrexate treatment for non-tubal ectopic pregnancies: a case series.

Molecular diagnostics and therapeutics for ectopic pregnancy.

Treatment of early-onset preeclampsia with continuous positive airway pressure.

Obstructive sleep apnea and pregnancy: the effect on perinatal outcomes.

Can we predict sleep-disordered breathing in pregnancy? The clinical utility of symptoms.

Identifying late onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks gestation.

Placental insufficiency in fetuses that slow in growth but are born appropriate for gestational age: A prospective longitudinal study.

Measuring hypoxia-induced RNA in maternal blood: a new way to identify critically hypoxic fetuses in utero?

Sign up to get our latest updates